Skip to main content

Localized Tongue Amyloidosis in a Patient with Neurofibromatosis Type II

Head and Neck Pathology volume 5, pages 302–305 (2011)Cite this article

Abstract

Background

Localized Amyloidosis (AL) may rarely involve oral mucosa. This is the first known reported case describing the development of tongue AL in a 30-year-old patient with Neurofibromatosis (NF) type-2.

Case

A female patient presented with a painless, well-circumscribed nodule of the tongue. Her medical history included NF type-2 with chromosome-22 abnormal karyotype (mosaicism), multiple intracranial and spinal meningiomas/schwannomas and unilateral blindness/deafness. The biopsy of the excised lesion of the tongue revealed subepithelial accumulation of an amorphous, nodular, fibrillar material positive for Congo red. Blood examination showed increased Thyroxine-T4 due to thyroid multinodular colloid goiter, but excluded any other hematological/immunological disorder or organ dysfunction. No recurrence was observed after a six-month follow-up.

Conclusion

This case highlights the possibility of oral manifestations as the only sign of AL and reveals the unexpected co-existence of AL and NF 2, for the first time.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price includes VAT (USA)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med. 2003;349(6):583–6.

    PubMed  Article  CAS  Google Scholar 

  2. Hierschfield GM. Amyloidosis: a clinic-pathophysiological synopsis. Semin Cell Develop Biol. 2004;15:39–44.

    Article  Google Scholar 

  3. Westermark P, Benson MD, Buxbaum JN, et al. A primer of amyloid nomeclature. Amyloid. 2007;14:179–83.

    PubMed  Article  CAS  Google Scholar 

  4. Petersson T, Konttinen YT. Amyloidosis-recent developments. Semin Arthritis Rheum. 2010;39(5):356–8.

    Article  Google Scholar 

  5. Merlini G, Westermark P. The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies. J Intern Med. 2004;255(2):159–78.

    PubMed  Article  CAS  Google Scholar 

  6. Penner CR, Muller S. Head and neck amyloidosis: a clinicopathologic study of 15 cases. Oral Oncol. 2006;42(4):421–9.

    PubMed  Article  Google Scholar 

  7. Kasper DS, Braunwald E, Fauci AS, Houser SL, Longo DL, Jameson JL. Harrison’s principles of internal medicine. 6th ed. Mac Graw-Hill, Medical Publishing Division 2005;2024.

  8. Neville BW, Damm DD, Allen CM, Bouquot JE. Oral and maxillofacial pathology. 3rd ed. Saunders Elsevier 2009;822.

  9. Stoopler ET, Sollecito TP, Chen SY. Amyloid deposition in the oral cavity: a retrospective study and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95(6):674–80.

    PubMed  Article  Google Scholar 

  10. Serdar A, Basak D, Sercan G, et al. Solitary amyloid tumor of the tongue base. Int J Otolaryngol. 2009;2009:515068-71.

  11. Henley E, Houghton N, Bucknall R, et al. Localized amyloidosis of the palate. Clin Exp Dermatol. 2008;33(1):100–1.

    PubMed  CAS  Google Scholar 

  12. Laskaris G. Pocket atlas of oral diseases. 2nd ed. Georg Thieme Verlag 2006;290.

  13. Antinheimo J, Sankila R, Carpen O, et al. Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology. 2000;54(1):71–6.

    PubMed  CAS  Google Scholar 

  14. Mautner VF, Lindenau M, Baser ME, et al. The neuroimaging and clinical spectrum of neurofibromatosis 2. Neurosurg. 1996;38:880–5.

    Article  CAS  Google Scholar 

  15. Kanter WR, Eldridge R, Fabricant A, et al. Central neurofibromatosis with bilateral with bilateral acoustic neuroma. Genetic clinical and biochemical distinctions from peripheral neurofibromatosis. Neurology. 1980;30:851–9.

    PubMed  CAS  Google Scholar 

  16. Ruggieri M, Huson SM. The clinical and diagnostic implications of mosaicism in the neurofibromatoses. Neurology. 2001;56:1433–43.

    PubMed  CAS  Google Scholar 

  17. Bongiorno MR, Pistone G, Aricò M. Manifestations of the tongue in neurofibromatosis type 1. Oral Dis. 2006;12(2):125–9.

    PubMed  Article  CAS  Google Scholar 

  18. Kang J, Khang SK, Choi J, et al. Intraneural perineurioma in the tongue. Korean J Pathol. 2007;41:51–4.

    Google Scholar 

  19. Barsley RE, Cottone JA. Oral manifestations of neurofibromatosis types I and II. Oral Surg Oral Med Oral Pathol. 1992;73:376–82.

    Article  Google Scholar 

  20. Mautner VF, Lindenau M, Baser ME, Kluwe L, Gottschalk J. Skin abnormalities in neurofibromatosis 2. Arch Dermatol. 1997;133(12):1539–43.

    PubMed  Article  CAS  Google Scholar 

  21. Khan MF, Falk RH. Amyloidosis. Postgrad Med J. 2001;77(913):686–93.

    PubMed  Article  CAS  Google Scholar 

  22. Steciuk A, Dompmartin A, Troussard X, et al. Cutaneous amyloidosis and possible association with systemic amyloidosis. Int J Dermatol. 2002;41(3):127–34.

    PubMed  Article  Google Scholar 

  23. van der Waal RI, van de Scheur MR, Huijgens PC, et al. Amyloidosis of the tongue as a paraneoplastic marker of plasma cell dyscrasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;94(4):444–7.

    PubMed  Article  Google Scholar 

  24. Sanchorawala V, Blanchard E, Seldin DC, et al. AL amyloidosis associated with B-cell lymphoproliferative disorders: frequency and treatment outcomes. Am J Hematol. 2006;81(9):692–5.

    PubMed  Article  CAS  Google Scholar 

  25. Falk RH, Skinner M. The systemic amyloidoses: an overview. Adv Intern Med. 2000;45:107–37.

    PubMed  CAS  Google Scholar 

  26. Rivera RJ, Vicenty S. Cardiac manifestations of amyloid disease. Bol Asoc Med P R. 2008;100(4):60–70.

    PubMed  Google Scholar 

  27. Nishi S, Alchi B, Imai N. New advances in renal amyloidosis. Clin Exp Nephrol. 2008;12(2):93–101.

    PubMed  Article  CAS  Google Scholar 

  28. Petre S, Shah IA, Gilani N. Review article: gastrointestinal amyloidosis—clinical features, diagnosis and therapy. Aliment Pharmacol Ther. 2008;27(11):1006–16.

    PubMed  Article  CAS  Google Scholar 

  29. Simmons Z, Specht CS. The neuromuscular manifestations of amyloidosis. J Clin Neuromuscul Dis. 2010;11(3):145–57.

    PubMed  Article  Google Scholar 

  30. Kerner MM, Wang MB, Angier G, et al. Amyloidosis of the head and neck. A clinicopathologic study of the UCLA experience, 1955–1991. Arch Otolaryngol Head Neck Surg. 1995;121(7):778–82.

    PubMed  CAS  Google Scholar 

  31. Angiero F, Seramondi R, Magistro S, et al. Amyloid deposition in the tongue: clinical and histopathological profile. Anticancer Res. 2010;30(7):3009–14.

    PubMed  Google Scholar 

  32. Fahrner KS, Black CC, Gosselin BJ. Localized amyloidosis of the tongue: a review. Am J Otolaryngol. 2004;25(3):186–9.

    PubMed  Article  Google Scholar 

  33. Pentenero M, Davico Bonino L. Localized oral amyloidosis of the palate. Amyloid. 2006;13(1):42–6.

    PubMed  Article  CAS  Google Scholar 

  34. Aono J, Yamagata K, Yoshida H. Local amyloidosis in the hard palate: a case report. Oral Maxillofac Surg. 2009;13(2):119–22.

    PubMed  Article  Google Scholar 

  35. Koloktronis A, Chatzigiannis I, Paloukidou N. Oral involvement in a case of AA amyloidosis. Oral Dis. 2003;9(5):269–72.

    PubMed  Article  CAS  Google Scholar 

  36. Kokong DD, Ibekwe TS, Okolo CA, et al. Amyloid angiopathy of the floor of the mouth: a case report and review of the literature. J Med Case Reports. 2007;1:117–20.

    PubMed  Article  Google Scholar 

  37. Myssiorek D, Alvi A, Bhuiya T. Primary salivary gland amyloidosis causing sicca syndrome. Ann Otol Rhinol Laryngol. 1992;101(6):487–90.

    PubMed  CAS  Google Scholar 

  38. Caporali R, Bonacci E, Epis O, et al. Safety and usefulness of minor salivary gland biopsy: retrospective analysis of 502 procedures performed at a single center. Arthritis Rheum. 2008;59(5):714–20.

    PubMed  Article  Google Scholar 

  39. Finkel KJ, Kolansky DM, Giorgadze T, et al. Amyloid infiltration of the salivary glands in the setting of primary systemic amyloidosis without multiple myeloma. Otolaryngol Head Neck Surg. 2006;135(3):471–2.

    PubMed  Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oral Medicine/Pathology, School of Dentistry, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece

    Dimitrios Andreadis, Athanasios Poulopoulos, Petros Papadopoulos & Apostolos Epivatianos

Authors
  1. Dimitrios Andreadis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Athanasios Poulopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Petros Papadopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Apostolos Epivatianos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dimitrios Andreadis.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Andreadis, D., Poulopoulos, A., Papadopoulos, P. et al. Localized Tongue Amyloidosis in a Patient with Neurofibromatosis Type II. Head and Neck Pathol 5, 302–305 (2011). https://doi.org/10.1007/s12105-011-0251-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12105-011-0251-5

Keywords

  • Oral amyloidosis
  • Neurofibromatosis type II